Sat.Feb 15, 2020 - Fri.Feb 21, 2020

article thumbnail

McKinsey’s Private Markets Annual Review

McKinsey Operations

Updated annually, our Private Markets Review offers the best of our research and insight into private equity, private real estate, and other private markets. Explore the findings from our most recent report and scroll for past years’ reports.

article thumbnail

Cybersecurity Risks Where You Least Expect Them

GDB Firm Blog

Approaching my first blogging anniversary, I am honored that Feedspot.com has named this one of the world's top 75 Bank Blogs. I'm glad to be in the top 75, and I hope, with your help as a blog follower, or even better if you link to this blog, to vault rapidly up the ladder. Let's quickly segue to my favorite topic these days, cybersecurity.

article thumbnail

CAR T-Cell Therapy Takes Off and Brings on Patent Litigation

Bio Law Blog

CAR T-Cell therapy, a new biologic therapy, is taking off. As companies continue to develop this new and promising therapy, patent litigation inevitably follows. CAR T-Cell therapy can be thought of as turbo-charging a patient’s own T-cells to treat cancer. At a high level, CAR T-Cell therapy works as follows: (1) a patient’s own T-cells are extracted and shipped to a laboratory, (2) scientists genetically engineer the T-cells to express a chimeric antigen receptor (CAR) that will re